Show simple item record

dc.contributor.authorYee, Y.
dc.contributor.authorChong, S.
dc.contributor.authorPervaiz, Shazib
dc.date.accessioned2017-03-17T08:29:05Z
dc.date.available2017-03-17T08:29:05Z
dc.date.created2017-02-19T19:31:46Z
dc.date.issued2016
dc.identifier.citationYee, Y. and Chong, S. and Pervaiz, S. 2016. The anti-oxidant and pro-oxidant dichotomy of Bcl-2.. Biol Chem. 397 (7): pp. 585-593.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/50917
dc.identifier.doi10.1515/hsz-2016-0127
dc.description.abstract

Across a wide spectrum of cellular redox status, there emerges a dichotomy of responses in terms of cell survival/proliferation and cell death. Of note, there is emerging evidence that the anti-apoptotic protein, Bcl-2, in addition to its conventional activity of titrating the pro-apoptotic effects of proteins such as Bax and Bak at the mitochondria, also impacts cell fate decisions via modulating cellular redox metabolism. In this regard, both pro- and anti-oxidant effects of Bcl-2 overexpression have been described under different conditions and cellular contexts. In this short review, we attempt to analyze existing observations and present a probable explanation for the seemingly conflicting redox regulating activity of Bcl-2 from the standpoint of its pro-survival function. The consequential effect(s) of the dual redox functions of Bcl-2 are also discussed, particularly from the viewpoint of developing novel therapeutic strategies against cancers rendered refractory due to the aberrant expression of Bcl-2.

dc.titleThe anti-oxidant and pro-oxidant dichotomy of Bcl-2.
dc.typeJournal Article
dcterms.source.volume397
dcterms.source.number7
dcterms.source.startPage585
dcterms.source.endPage593
dcterms.source.titleBiol Chem
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record